Expression of DARC, CXCR3 and CCR5 in giant cell arteritis

Rheumatology

Volumn 44, Issue 3, 2005, Pages 309-313

  Brühl, Hilke ^a   Vielhauer, V ^a   Weiss, M ^a   Mack, M ^a   Schlondorff D ^a   Segerer, S ^a  

^a UNIVERSITY OF MUNICH   (Germany)

Author keywords

CCL5; CCR5; Chemokine; Chemokine receptor; CXCR3; DARC; Duffy antigen receptor for chemokines; Giant cell arteritis; RANTES

Indexed keywords

CHEMOKINE; CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR3; DUFFY ANTIGEN RECEPTOR OF CHEMOKINE; MESSENGER RNA; RANTES; UNCLASSIFIED DRUG;

ADVENTITIA; ARTICLE; BLOOD VESSEL BIOPSY; CELL INFILTRATION; CLINICAL ARTICLE; CLUSTER ANALYSIS; CONTROLLED STUDY; GIANT CELL ARTERITIS; HUMAN; HUMAN TISSUE; IMMUNOHISTOLOGY; IMMUNOPATHOGENESIS; IN SITU HYBRIDIZATION; LEUKOCYTE MIGRATION; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RHEUMATIC POLYMYALGIA; TEMPORAL ARTERY; TISSUE SECTION; VASCULAR ENDOTHELIUM; VENULE;

BIOLOGICAL MARKERS; CHEMOKINES, CC; DUFFY BLOOD-GROUP SYSTEM; GENE EXPRESSION; HUMANS; LEUKOCYTES; MIDDLE AGED; MONOCYTES; POLYMYALGIA RHEUMATICA; RANTES; RECEPTORS, CCR5; RECEPTORS, CELL SURFACE; RECEPTORS, CHEMOKINE; RNA, MESSENGER; T-LYMPHOCYTES; TEMPORAL ARTERIES; TEMPORAL ARTERITIS;

EID: 14944355933     PISSN: 14620324     EISSN: None     Source Type: Journal    
DOI: 10.1093/rheumatology/keh485     Document Type: Article

References (20)

1. Sallusto F, Lenig D, Mackay CR, Lanzavecchia A. Flexible programs of chemokine receptor expression on human polarized T helper 1 and 2 lymphocytes. Exp Med 1998;187:875-83.
2. Middleton J, Patterson AM, Gardner L, Schmutz C, Ashton BA. Leukocyte extravasation: chemokine transport and presentation by the endothelium. Blood 2002;100:3853-60.
3. Neote K, Darbonne W, Ogez J, Horuk R, Schall TJ. Identification of a promiscuous inflammatory peptide receptor on the surface of red blood cells. J Biol Chem 1993;68:12247-9.
4. Hunder GG, Bloch DA, Michel BA et al. The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis. Arthritis Rheum 1990;33:1122-8.
5. Mack M, Brühl H, Gruber R et al. Predominance of mononuclear cells expressing the chemokine receptor CCR5 in synovial effusions of patients with different forms of arthritis. Arthritis Rheum 1999;42:981-8.
6. Segerer S, Mack M, Regele H, Kerjaschki D, Schlöndorff D. Expression of the C-C chemokine receptor 5 in human kidney diseases. Kidney Int 1999;56:52-64.
7. Segerer S, Bohmig GA, Exner M et al. When renal allografts turn DARC. Transplantation 2003;75:1030-4.
8. Vielhauer V, Anders AJ, Mack M et al. Obstructive nephropathy in the mouse: progressive fibrosis correlates with tubulointerstitial chemokine expression and accumulation of CC chemokine receptor 2- and 5-positive leukocytes. J Am Soc Nephrol 2001;12: 1173-87.
9. Brühl H, Wagner K, Kellner H, Schattenkirchner M, Schlöndorff D, Mack M. Surface expression of CC- and CXC-chemokine receptors on leucocyte subsets in inflammatory joint diseases. Clin Exp Immunol 2001;126:551-9.
10. de Roda Husman AM, Blaak H, Brouwer M, Schuitemaker H. CC chemokine receptor 5 cell-surface expression in relation to CC chemokine receptor 5 genotype and the clinical course of HIV-1 infection. J Immunol 1999;163:4597-603.
11. Ostrowski MA, Justement SJ, Catanzaro A et al. Expression of chemokine receptors CXCR4 and CCR5 in HIV-1-infected and uninfected individuals. J Immunol 1998;161:3195-201.
12. Weyand CM, Hicok KC, Hunder GG, Goronzy JJ. Tissue cytokine patterns in patients with polymyalgia rheumatica and giant cell arteritis. Ann Intern Med 1994;121:484-91.
13. Wagner AD, Bjornsson J, Bartley GB, Goronzy JJ, Weyand CM. Interferon-gamma-producing T cells in giant cell vasculitis represent a minority of tissue-infiltrating cells and are located distant from the site of pathology. Am J Pathol 1996;148:1925-33.
14. Mach F, Sauty A, Iarossi AS et al. Differential expression of three T lymphocyte-activating CXC chemokines by human atheroma-associated cells. J Clin Invest 1999;104:1041-50.
15. Chaudhuri A, Nielsen S, Elkjaer ML, Zbrzezna V, Fang F, Pogo AO. Detection of duffy antigen in the plasma membranes and caveolae of vascular endothelial and epithelial cells of nonerythroid organs. Blood 1997;89:701-12.
16. Segerer S, Regele H, Mac KM et al. The Duffy antigen receptor for chemokines is up-regulated during acute renal transplant rejection and crescentic glomerulonephritis. Kidney Int 2000;58: 1546-56.
17. Liu XH, Hadley TJ, Xu L, Peiper SC, Ray PE. Up-regulation of Duffy antigen receptor expression in children with renal disease. Kidney Int 1999;55:1491-500.
18. Dawson TC, Lentsch AB, Wang Z et al. Exaggerated response to endotoxin in mice lacking the Duffy antigen/receptor for chemokines (DARC). Blood 2000;96:1681-4.
19. Neote K, Mak JY, Kolakowski LF Jr, Schall TJ. Functional and biochemical analysis of the cloned Duffy antigen: identity with the red blood cell chemokine receptor. Blood 1994;84:44-52.
20. Nibbs R, Graham G, Rot A. Chemokines on the move: control by the chemokine 'interceptors' Duffy blood group antigen and D6. Semin Immunol 2003;15:287-97.